Published in Obesity and Diabetes Week, August 21st, 2006
According to a study from the United States, "This study compared the 1-year incidence of new-onset type-2 diabetes mellitus (DM) and changes in weight in patients with a variety of psychiatric diagnoses prescribed olanzapine, risperidone, or quetiapine, compared to a reference group receiving haloperidol and no other antipsychotic medication."
M.T. Lambert and colleagues at the University of Texas explained, Data was abstracted from charts of subjects newly initiated and then maintained for 1 year on olanzapine (n=112), risperidone (n=100), quetiapine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.